We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

EBR Systems Sees Leadership Transition, John McCutcheon Steps In

EBR Systems, Inc. announced the impending departure of its Chief Commercial Officer, Erik Strandberg, set to leave the company in the coming months. The specific date of his exit has not been finalized. The transition will not stem from any disagreements regarding the company's …

Vinay Lochav | 25 August 2026

Abbott's Revenue Rises 42% to $3.09B, Outshines Intuitive Surgical

Abbott's Revenue Surged to $3.09 Billion

Vinay Lochav | 25 August 2026

REGENXBIO (NASDAQ:RGNX) Crashes 24.86% as Gene-Therapy Catalysts Approach

REGENXBIO Inc. (NASDAQ:RGNX) shares fell 24.86% to $8.06 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

Lantern Pharma (NASDAQ:LTRN) Drops 9.83% as Warrant Accounting Widens Net Loss

Lantern Pharma Inc. (NASDAQ:LTRN) shares fell 9.83% to $2.11 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

Haoxi Health Technology (NASDAQ:HAO) Plunges 7.95% After an Eighth Recapitalization

Haoxi Health Technology Ltd (NASDAQ:HAO) shares fell 7.95% to $3.01 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

Hims & Hers (NYSE:HIMS) Slides 8.01% Even After Raising 2026 Revenue Guidance

Hims & Hers Health, Inc. (NYSE:HIMS) shares fell 8.01% to $31.08 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

EyePoint Pharmaceuticals (NASDAQ:EYPT) Falls 8.46% as Mixed Phase 3 Data Weighs on Shares

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) shares have been among the more volatile names onNasdaqthis month, with the stock falling 8.46% to $4.87 in the latest closing session and sitting near the low end of a 52-week range that stretches from $19.01 to $3.95.

Nitish Kishor | 25 August 2026

CDT Equity (NASDAQ:CDT) Slides 12.94% as Quantum-Computing Pivot Continues

CDT Equity Inc. (NASDAQ:CDT), formerly Conduit Pharmaceuticals Inc., saw shares fall 12.94% to $2.49 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

Conexeu Sciences (NASDAQ:CNXU) Falls 12.15% in Post-IPO Valuation Reset

Conexeu Sciences Inc. (NASDAQ:CNXU) shares fell 12.15% to $7.81 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026

Azenta (NASDAQ:AZTA) Sinks 12.09% as CEO Transition Takes Center Stage

Azenta, Inc. (NASDAQ:AZTA) shares fell 12.09% to $32.88 in the latest closing session, placing the stock among the day's most notable decliners.

Nitish Kishor | 25 August 2026
Support

Hi! How can we help you today?

Loading…